IP-10 protects while MIP-2 promotes experimental anesthetic hapten - induced hepatitis

Journal of Autoimmunity

Volumn 32, Issue 1, 2009, Pages 52-59

  Njoku, Dolores B ^a   Li, Zhaoxia ^a   Mellerson, Jenelle L ^a   Sharma, Rajni ^a   Talor, Monica V ^a   Barat, Nicole ^a   Rose, Noel R ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

CYP2E1; DILI; IP 10; KC chemokines; MIP 2; TFA; Trifluoroacetyl chloride

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HAPTEN;

ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EXPERIMENTAL ANIMAL; EXPERIMENTAL MOUSE; FEMALE; GRANULOCYTE; HEPATITIS; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE;

ANESTHETICS; ANIMALS; ANTIBODIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CHEMOKINE CXCL10; CHEMOKINE CXCL2; CHEMOKINE CXCL9; CYTOCHROME P-450 CYP2E1; FEMALE; HAPTENS; HEPATITIS, TOXIC; INTERLEUKIN-4; LIVER; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MODELS, IMMUNOLOGICAL; NEUTROPHILS; RECEPTORS, CXCR3; RECEPTORS, INTERLEUKIN-8B; SPLEEN; T-LYMPHOCYTES; TRIFLUOROACETIC ACID;

EID: 58849106238     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2008.11.003     Document Type: Article

References (50)

1. Zhou R., Tang W., Ren Y.X., He P.L., Yang Y.F., Li Y.C., et al. Preventive effects of (5R)-5-hydroxytriptolide on concanavalin A-induced hepatitis. Eur J Pharmacol 537 (2006) 181-189
2. Bourdi M., Chen W., Peter R.M., Martin J.L., Buters J.T., Nelson S.D., et al. Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis. Chem Res Toxicol 9 (1996) 1159-1166
3. Mackay I.R., and Toh B.H. Autoimmune hepatitis: the way we were, the way we are today and the way we hope to be. Autoimmunity 35 (2002) 293-305
4. Neuberger J., Mieli-Vergani G., Tredger J.M., Davis M., and Williams R. Oxidative metabolism of halothane in the production of altered hepatocyte membrane antigens in acute halothane-induced hepatic necrosis. Gut 22 (1981) 669-672
5. Pohl L.R., Thomassen D., Pumford N.R., Butler L.E., Satoh H., Ferrans V.J., et al. Hapten carrier conjugates associated with halothane hepatitis. Adv Exp Med Biol 283 (1991) 111-120
6. Njoku D., Laster M.J., Gong D.H., Eger E.I., Reed G.F., and Martin J.L. Biotransformation of halothane, enflurane, isoflurane, and desflurane to trifluoroacetylated liver proteins: association between protein acylation and hepatic injury. Anesth Analg 84 (1997) 173-178
7. Njoku D.B., Talor M.V., Fairweather D., Frisancho-Kiss S., Odumade O.A., and Rose N.R. A novel model of drug hapten-induced hepatitis with increased mast cells in the BALB/c mouse. Exp Mol Pathol 78 (2005) 87-100
8. Molnar R.G., Wang P., Ayala A., Ganey P.E., Roth R.A., and Chaudry I.H. The role of neutrophils in producing hepatocellular dysfunction during the hyperdynamic stage of sepsis in rats. J Surg Res 73 (1997) 117-122
9. Lawson J.A., Farhood A., Hopper R.D., Bajt M.L., and Jaeschke H. The hepatic inflammatory response after acetaminophen overdose: role of neutrophils. Toxicol Sci 54 (2000) 509-516
10. Taieb J., Chollet-Martin S., Cohard M., Garaud J.J., and Poynard T. The role of interleukin-10 in severe acute alcoholic hepatitis. Clin Biochem 34 (2001) 237-238
11. Gregory S.A., Webster J.B., and Chapman G.D. Acute hepatitis induced by parenteral amiodarone. Am J Med 113 (2002) 254-255
12. Pham B.N., Bemuau J., Durand F., Sauvanet A., Degott C., Prin L., et al. Eotaxin expression and eosinophil infiltrate in the liver of patients with drug-induced liver disease. J Hepatol 34 (2001) 537-547
13. Louis H., Le Moine A., Flamand V., Nagy N., Quertinmont E., Paulart F., et al. Critical role of interleukin 5 and eosinophils in concanavalin A-induced hepatitis in mice. Gastroenterology 122 (2002) 2001-2010
14. Tsutsui H., Matsui K., Okamura H., and Nakanishi K. Pathophysiological roles of interleukin-18 in inflammatory liver diseases. Immunol Rev 174 (2000) 192-209
15. Sass G., Heinlein S., Agli A., Bang R., Schumann J., and Tiegs G. Cytokine expression in three mouse models of experimental hepatitis. Cytokine 19 (2002) 115-120
16. Yumoto E., Higashi T., Nouso K., Nakatsukasa H., Fujiwara K., Hanafusa T., et al. Serum gamma-interferon-inducing factor (IL-18) and IL-10 levels in patients with acute hepatitis and fulminant hepatic failure. J Gastroenterol Hepatol 17 (2002) 285-294
17. Colantoni A., Idilman R., De Maria N., La Paglia N., Belmonte J., Wezeman F., et al. Hepatic apoptosis and proliferation in male and female rats fed alcohol: role of cytokines. Alcohol Clin Exp Res 27 (2003) 1184-1189
18. Enomoto N., Takei Y., Hirose M., Kitamura T., Ikejima K., and Sato N. Protective effect of thalidomide on endotoxin-induced liver injury. Alcohol Clin Exp Res 27 (2003) 2S-6S
19. Endlich B., Armstrong D., Brodsky J., Novotny M., and Hamilton T.A. Distinct temporal patterns of macrophage-inflammatory protein-2 and KC chemokine gene expression in surgical injury. J Immunol 168 (2002) 3586-3594
20. Armstrong D.A., Major J.A., Chudyk A., and Hamilton T.A. Neutrophil chemoattractant genes KC and MIP-2 are expressed in different cell populations at sites of surgical injury. J Leukoc Biol 75 (2004) 641-648
21. Rovai L.E., Herschman H.R., and Smith J.B. The murine neutrophil-chemoattractant chemokines LIX, KC, and MIP-2 have distinct induction kinetics, tissue distributions, and tissue-specific sensitivities to glucocorticoid regulation in endotoxemia. J Leukoc Biol 64 (1998) 494-502
22. Hall L.R., Diaconu E., Patel R., and Pearlman E. CXC chemokine receptor 2 but not C-C chemokine receptor 1 expression is essential for neutrophil recruitment to the cornea in helminth-mediated keratitis (river blindness). J Immunol 166 (2001) 4035-4041
23. Kopydlowski K.M., Salkowski C.A., Cody M.J., van Rooijen N., Major J., Hamilton T.A., et al. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo. J Immunol 163 (1999) 1537-1544
24. Jaruga B., Hong F., Kim W.H., and Gao B. IFN-gamma/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1. Am J Physiol Gastrointest Liver Physiol 287 (2004) G1044-G1052
25. Ishida Y., Kondo T., Ohshima T., Fujiwara H., Iwakura Y., and Mukaida N. A pivotal involvement of IFN-gamma in the pathogenesis of acetaminophen-induced acute liver injury. FASEB J 16 (2002) 1227-1236
26. Bone-Larson C.L., Hogaboam C.M., Evanhoff H., Strieter R.M., and Kunkel S.L. IFN-gamma-inducible protein-10 (CXCL10) is hepatoprotective during acute liver injury through the induction of CXCR2 on hepatocytes. J Immunol 167 (2001) 7077-7083
27. Booth V., Keizer D.W., Kamphuis M.B., Clark-Lewis I., and Sykes B.D. The CXCR3 binding chemokine IP-10/CXCL10: structure and receptor interactions. Biochemistry 41 (2002) 10418-10425
28. Howell C.D., and Yoder T.D. Murine experimental autoimmune hepatitis: nonspecific inflammation due to adjuvant oil. Clin Immunol Immunopathol 72 (1994) 76-82
29. Gerard C., and Rollins B.J. Chemokines and disease. Nat Immunol 2 (2001) 108-115
30. Huang S., Paulauskis J.D., Godleski J.J., and Kobzik L. Expression of macrophage inflammatory protein-2 and KC mRNA in pulmonary inflammation. Am J Pathol 141 (1992) 981-988
31. Arai K., Liu Z.X., Lane T., and Dennert G. IP-10 and Mig facilitate accumulation of T cells in the virus-infected liver. Cell Immunol 219 (2002) 48-56
32. Njoku D.B., Shrestha S., Soloway R., Duray P.R., Tsokos M., Abu-Asab M.S., et al. Subcellular localization of trifluoroacetylated liver proteins in association with hepatitis following isoflurane. Anesthesiology 96 (2002) 757-761
33. Anderson J.S., Rose N.R., Martin J.L., Eger E.I., and Njoku D.B. Desflurane hepatitis associated with hapten and autoantigen-specific IgG4 antibodies. Anesth Analg 104 (2007) 1452-1453 table
34. Nguyen C., Rose N.R., and Njoku D.B. Trifluoroacetylated IgG4 antibodies in a child with idiosyncratic acute liver failure after first exposure to halothane. J Pediatr Gastroenterol Nutr 47 (2008) 199-202
35. Chin M.W., Njoku D.B., Macquillan G., Cheng W.S., and Kontorinis N. Desflurane-induced acute liver failure. Med J Aust 189 (2008) 293-294
36. Bonder C.S., Ajuebor M.N., Zbytnuik L.D., Kubes P., and Swain M.G. Essential role for neutrophil recruitment to the liver in concanavalin A-induced hepatitis. J Immunol 172 (2004) 45-53
37. Hatada S., Ohta T., Shiratsuchi Y., Hatano M., and Kobayashi Y. A novel accessory role of neutrophils in concanavalin A-induced hepatitis. Cell Immunol 233 (2005) 23-29
38. Hatano M., Sasaki S., Ohata S., Shiratsuchi Y., Yamazaki T., Nagata K., et al. Effects of Kupffer cell-depletion on concanavalin A-induced hepatitis. Cell Immunol 251 (2008) 25-30
39. Serbina N.V., and Pamer E.G. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 7 (2006) 311-317
40. Stefanovic L., Brenner D.A., and Stefanovic B. Direct hepatotoxic effect of KC chemokine in the liver without infiltration of neutrophils. Exp Biol Med (Maywood) 230 (2005) 573-586
41. Bajt M.L., Farhood A., and Jaeschke H. Effects of CXC chemokines on neutrophil activation and sequestration in hepatic vasculature. Am J Physiol Gastrointest Liver Physiol 281 (2001) G1188-G1195
42. Wang J., Zhao J.H., Wang P.P., and Xiang G.J. Expression of CXC chemokine IP-10 in patients with chronic hepatitis B. Hepatobiliary Pancreat Dis Int 7 (2008) 45-50
43. Deng G., Zhou G., Zhang R., Zhai Y., Zhao W., Yan Z., et al. Regulatory polymorphisms in the promoter of CXCL10 gene and disease progression in male hepatitis B virus carriers. Gastroenterology 134 (2008) 716-726
44. Lagging M., Romero A.I., Westin J., Norkrans G., Dhillon A.P., Pawlotsky J.M., et al. IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection. Hepatology 44 (2006) 1617-1625
45. Romero A.I., Lagging M., Westin J., Dhillon A.P., Dustin L.B., Pawlotsky J.M., et al. Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection. J Infect Dis 194 (2006) 895-903
46. Chuang Y.H., Lian Z.X., Cheng C.M., Lan R.Y., Yang G.X., Moritoki Y., et al. Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives. J Autoimmun 25 (2005) 126-132
47. Rieger R., and Gershwin M.E. The X and why of xenobiotics in primary biliary cirrhosis. J Autoimmun 28 (2007) 76-84
48. Nakae S., Komiyama Y., Narumi S., Sudo K., Horai R., Tagawa Y., et al. IL-1-induced tumor necrosis factor-alpha elicits inflammatory cell infiltration in the skin by inducing IFN-gamma-inducible protein 10 in the elicitation phase of the contact hypersensitivity response. Int Immunol 15 (2003) 251-260
49. Gasperini S., Marchi M., Calzetti F., Laudanna C., Vicentini L., Olsen H., et al. Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils. J Immunol 162 (1999) 4928-4937
50. Njoku et al., in press, Eur J Immunol.